Committee defers medication‑labeling bill after safety, logistical concerns over anonymous labeling
SB 20-38, which would allow anonymized labeling for some medications including abortion drugs, drew divided testimony on patient safety and pharmacy operations; the chair recommended deferral after questions about FDA rules, mail‑order logistics and potential costs.
The full story
SB 20-38, a measure that would alter medication-labeling requirements to allow limited identifying information on certain dispensings, prompted extensive testimony and operational questioning before the committee recommended deferral.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
or